BA PHARMA

Active

Private limited companyfounded 2018active for 7 yearsRue Lambot(AI) 56, 6250 Aiseau-Presles, BelgiumKBO/BCE: BE 0715.554.548

Summary

The computed 12-month bankruptcy probability of BA PHARMA is 1.6% (moderate). The 2025 annual accounts show equity of €146,387 and a net result of €689. Equity is growing by about 14% per year across the filed financial years. Its solvency ranks better than 18% of 12,678 sector peers (NACE 47, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

BA PHARMAActiveChecked score 55/100

Risk analysis Report Compare

Directors

1 director

BAELENAnneCindyBrigitte

Administrateurnonstatutaire

Current

Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ. See the directors and other office holders in the KBO →

Not every act has been read: a resignation may still be missing

4 of this company's 5 Belgian Official Gazette deeds have not been read yet. Appointments and resignations recorded in them are not yet in the list of directors: someone who resigned there may still be listed as sitting. The acts are in the Timeline.

Mandate history

1 person since 2023, 1 in office

All 1 In office 1

Board
began earlier

Mandates per person, with start and end dates
Name	Functions and periods
BAELENAnneCindyBrigitte	Administrateurnonstatutaire, since before 11-10-2023

See the board, name and registered office on a given date →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.